To combat viruses, one of humankind’s oldest threats, researchers are studying predators with the oldest adaptive immune system in the animal kingdom: sharks.

Medical research has benefitted from the scale, speed and efficiency of COVID-19 studies, and scientists are using the techniques developed to fight the pandemic in the race to stay ahead of emerging diseases.

Ultrabright light from the Advanced Photon Source continues to illuminate mysteries around coronaviruses and shape the vaccines and therapeutics protecting us against variants of concern.

In two recent studies, researchers using the Advanced Photon Source have identified existing drugs that may inhibit the virus that causes COVID-19.

Researchers have developed antibodies that can bind to phosphohistidine, an unstable molecule that’s linked to cancer. To learn how the two bind together, the team turned to the powerful X-rays at Argonne’s Advanced Photon Source.

A novel pipeline of AI and simulation tools may make the process of screening drug candidates for COVID-19 50,000 times faster.

Research team uses powerful X-rays to uncover the structure and behavior of proteins regulating tarantula muscle movement, which could teach us more about our own muscles.

Alzheimer’s disease is the sixth leading cause of death in the United States, affecting one in 10 people over the age of 65. Scientists are engineering nanodevices to disrupt processes in the brain that lead to the disease.

Argonne is bringing the power of its scientific leadership and state-of-the-art user facilities to bear in the global battle against COVID-19.